Content area

|
|

Kronisk inflammatorisk demyeliniserende polyneuropati

Forfatter(e)
Lars Kjøbsted Markvardsen1, 2, Thomas Harbo1, Jakob Vormstrup Holbech3, Hatice Tankisi4, Ingelise Christiansen5, Niels Kjær Olsen2, Johannes Jakobsen6, Søren Hein Sindrup3 & Henning Andersen1 *
1) Neurologi, Aarhus Universitetshospital 2) Neurologisk Afdeling, Aalborg Universitetshospital 3) Neurologisk Afdeling, Odense Universitetshospital 4) Neurofysiologisk Klinik, Neurologi, Aarhus Universitetshospital 5) Neurologisk Klinik, Rigshospitalet 6) Institut for Klinisk Medicin, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet

Ugeskr Læger 2019;181:V02190079
Reference: 
Ugeskr Læger 2019;181:V02190079

Lars Kjøbsted Markvardsen, Thomas Harbo, Jakob Vormstrup Holbech, Hatice Tankisi,
Ingelise Christiansen, Niels Kjær Olsen, Johannes Jakobsen, Søren Hein Sindrup
& Henning Andersen:

Chronic inflammatory demyelinating polyneuropathy

Ugeskr Læger 2019;181:V02190079

In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves. CIDP can be successfully treated with immunoglobulin, glucocorticoids or plasma exchange, and during the latest decade, immunoglobulin has been administered subcutaneously improving patients’ flexibility and autonomy. By time, 30% of the patients will remit, and maintenance treatment will no longer be necessary.

Du skal være logget ind for at læse denne artikel
Log ind

Right side